Effects of intake of 11/19-B1 Yogurt on dialysis patients.

Verification of the effects of intaking "11/19-B1 Yogurt" on serum uremic toxins, LDL levels, immune function and improvement of defecation in dialysis patients - Single group study - - Verification of the effect of intaking "11/19-B1 Yogurt" on dialysis patients.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050555

Enrollment

Registered

2023-03-11

Start date

2023-03-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

To intake &quot

11/19-B1 Yogurt&quot

(50g/day) for 8 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Those who are undergoing dialysis treatment and have no milk allergy Patients who consented to participate in this study

Exclusion criteria

Exclusion criteria: Subjects with milk allergy

Design outcomes

Primary

Measure	Time frame
Blood indoxyl sulfate concentration Blood trimethylamine N oxide Serum LDL level Cellular immunity Defecation evaluation (These tests are evaluated 4 weeks before intake, before intake, 4 weeks and 8 weeks after intake, and 4 weeks and 8 weeks after the end of intake.)	—

Secondary

Measure	Time frame
Stool test (fecal intestinal flora) regular inspection	—

Countries

Japan

Contacts

Public ContactTatsuo Suzutani

Fukushima Medical University Department of Microbiology

suzutani@fmu.ac.jp0245471158

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026